Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 CNS cancer: Glioblastoma subtypes revisited.

Literature DB >> 28762385

CNS cancer: Glioblastoma subtypes revisited.

Peter Sidaway.

Abstract

Entities: Disease

Year: 2017 PMID： 28762385 DOI： 10.1038/nrclinonc.2017.122

Source DB: PubMed Journal: Nat Rev Clin Oncol ISSN： 1759-4774 Impact factor: 66.675

× No keyword cloud information.

1 in total

1. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.

Authors: Qianghu Wang; Baoli Hu; Xin Hu; Hoon Kim; Massimo Squatrito; Lisa Scarpace; Ana C deCarvalho; Sali Lyu; Pengping Li; Yan Li; Floris Barthel; Hee Jin Cho; Yu-Hsi Lin; Nikunj Satani; Emmanuel Martinez-Ledesma; Siyuan Zheng; Edward Chang; Charles-Etienne Gabriel Sauvé; Adriana Olar; Zheng D Lan; Gaetano Finocchiaro; Joanna J Phillips; Mitchel S Berger; Konrad R Gabrusiewicz; Guocan Wang; Eskil Eskilsson; Jian Hu; Tom Mikkelsen; Ronald A DePinho; Florian Muller; Amy B Heimberger; Erik P Sulman; Do-Hyun Nam; Roel G W Verhaak
Journal: Cancer Cell Date: 2017-07-10 Impact factor: 31.743

1 in total

19 in total

1. PNJ scaffolds promote microenvironmental regulation of glioblastoma stem-like cell enrichment and radioresistance.

Authors: John M Heffernan; James B McNamara; Brent L Vernon; Shwetal Mehta; Rachael W Sirianni
Journal: Biomater Sci Date: 2022-02-01 Impact factor: 6.843

Review 2. Genes of the Ubiquitin Proteasome System Qualify as Differential Markers in Malignant Glioma of Astrocytic and Oligodendroglial Origin.

Authors: Jerry Vriend; Thomas Klonisch
Journal: Cell Mol Neurobiol Date: 2022-07-27 Impact factor: 4.231

3. Aberrant Protein Glycosylation in Brain Cancers, with Emphasis on Glioblastoma.

Authors: Livia Rosa-Fernandes; Sueli Mieko Oba-Shinjo; Janaina Macedo-da-Silva; Suely Kazue Nagahashi Marie; Giuseppe Palmisano
Journal: Adv Exp Med Biol Date: 2022 Impact factor: 3.650

4. Validation of Anticorrelated TGFβ Signaling and Alternative End-Joining DNA Repair Signatures that Predict Response to Genotoxic Cancer Therapy.

Authors: Ines Guix; Qi Liu; Miquel Angel Pujana; Patrick Ha; Josep Piulats; Isabel Linares; Ferran Guedea; Jian-Hua Mao; Ann Lazar; Jocelyn Chapman; Sue S Yom; Alan Ashworth; Mary Helen Barcellos-Hoff
Journal: Clin Cancer Res Date: 2022-04-01 Impact factor: 13.801

5. Angiogenin and plexin-B2 axis promotes glioblastoma progression by enhancing invasion, vascular association, proliferation and survival.

Authors: Hailing Yang; Liang Yuan; Soichiro Ibaragi; Shuping Li; Robert Shapiro; Nil Vanli; Kevin A Goncalves; Wenhao Yu; Hiroko Kishikawa; Yuxiang Jiang; Alexander J Hu; Daniel Jay; Brent Cochran; Eric C Holland; Guo-Fu Hu
Journal: Br J Cancer Date: 2022-04-13 Impact factor: 9.075

Review 6. A review of glioblastoma immunotherapy.

Authors: Ravi Medikonda; Gavin Dunn; Maryam Rahman; Peter Fecci; Michael Lim
Journal: J Neurooncol Date: 2020-04-06 Impact factor: 4.130

Review 7. Immunogenetics of glioblastoma: the future of personalized patient management.

Authors: Malak Abedalthagafi; Duna Barakeh; Kara M Foshay
Journal: NPJ Precis Oncol Date: 2018-12-04

8. Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types.

Authors: Qi Liu; Luis Palomero; Jade Moore; Ines Guix; Roderic Espín; Alvaro Aytés; Jian-Hua Mao; Amanda G Paulovich; Jeffrey R Whiteaker; Richard G Ivey; George Iliakis; Daxian Luo; Anthony J Chalmers; John Murnane; Miquel Angel Pujana; Mary Helen Barcellos-Hoff
Journal: Sci Transl Med Date: 2021-02-10 Impact factor: 17.956

Review 9. Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme.

Authors: Christopher Chin; Emma S Lunking; Macarena de la Fuente; Nagi G Ayad
Journal: Front Oncol Date: 2018-11-13 Impact factor: 6.244

10. Liposomal delivery of ferritin heavy chain 1 (FTH1) siRNA in patient xenograft derived glioblastoma initiating cells suggests different sensitivities to radiation and distinct survival mechanisms.

Authors: Vagisha Ravi; Achuthamangalam B Madhankumar; Thomas Abraham; Becky Slagle-Webb; James R Connor
Journal: PLoS One Date: 2019-09-06 Impact factor: 3.240